SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001646626-15-000004
Filing Date
2015-07-08
Accepted
2015-07-08 17:10:27
Documents
1
Period of Report
2015-07-01

Document Format Files

Seq Description Document Type Size
1 FORM 3 wf-form3_143638981749746.html 3  
1 FORM 3 wf-form3_143638981749746.xml 3 3132
  Complete submission text file 0001646626-15-000004.txt   4482
Mailing Address 10182 TELESIS COURT, 6TH FLOOR SAN DIEGO CA 92121
Business Address 10182 TELESIS COURT, 6TH FLOOR SAN DIEGO CA 92121 858-207-4264
LA JOLLA PHARMACEUTICAL CO (Issuer) CIK: 0000920465 (see all company filings)

IRS No.: 330361285 | State of Incorp.: CA | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 1960 KIRBY ROAD MCLEAN VA 22101
Business Address
Chawla Lakhmir S (Reporting) CIK: 0001646626 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36282 | Film No.: 15979814